Últimas noticias sobre Quantum BioPharma (NASDAQ:QNTM) Bolsa

Quantum BioPharma

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEMD

APCX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DALN

DSGN

ELAB

KULR

LITM

MESO

NVNI

PTPI

QNTM

SGMO

SLXN

VRAX

Acciones de Sangamo Therapeutics suben un 19,5% tras un nuevo acuerdo. Descubre los mayores ganadores y perdedores de hoy.

Acciones de Sangamo Therapeutics (SGMO) suben alrededor de un 20%; 20 acciones que se mueven en el premercado

Quantum Biopharma Ltd. - Class B Subordinate Voting Shares

Quantum BioPharma Ltd

Ideal Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPWR#NASDAQ">IPWR</a>) reported quarterly losses of $(0.30) per share. This is a 23.08 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $12.00 thousand which beat the analyst consensus estimate of $10.00 thousand by 20.03 percent. This is a 84.76 percent decrease over sales of $78.74 thousand the same period last year.

Earnings

Earnings Beats

IPWR

Ideal Power Q1 EPS $(0.30) Up From $(0.39) YoY, Sales $12.00K Beat $10.00K Estimate

<a href="https://www.mastercard.com/news/press/2025/may/mastercard-and-moonpay-team-up-to-mainstream-stablecoin-payments/" title="https://www.mastercard.com/news/press/2025/may/mastercard-and-moonpay-team-up-to-mainstream-stablecoin-payments/">https://www.mastercard.com/news/press/2025/may/mastercard-and-moonpay-team-up-to-mainstream-stablecoin-payments/</a>

'Mastercard And MoonPay Team Up To Mainstream Stablecoin Payments' - Newsroom

Addentax Group Corp. ("ATXG" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) today announced that it has been in&nbsp; discussions with a number of substantial and influential Bitcoin and other mainstream Cryptocurrency holders, to acquire up to 8,000 Bitcoins, together with other Cryptocurrencies, such as Official Trump, with an expected current market value of approximately USD 800 million, by issuing shares of common stock. No definitive agreement has been reached.&nbsp;
Based on separate conversations with the Crypto holders, it is believed that they collectively hold approximately 8,000 BTC, bearing profound understanding and networks in the Crypto world. Addentax Group Corp. and its management regard this initiative as the Company's core action to support its crypto asset long-term investment and holding strategy, at the same time, building up the Company's networks through bringing influential crypto holders as its shareholders.
ATXG aims to strengthen its balance sheet by acquiring highly-liquid and widely recognized digital assets, while also bringing in new shareholders with demonstrated experience and expertise in the cryptocurrency sector.
This potential plan reflects the management's long-term strategic view on the evolving digital asset landscape.&nbsp;

$BTC

$TRUMP

ATXG

Addentax Group Announces $800M Plan To Acquire Bitcoin And Official Trump

Bridgestone (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BRDCY#OTC">BRDCY</a>) reported quarterly earnings of $0.36 per share. This is a 16.28 percent decrease over earnings of $0.43 per share from the same period last year. The company reported $6.94 billion in sales this quarter. This is a 3.25 percent decrease over sales of $7.17 billion the same period last year.

BRDCY

Bridgestone Q1 GAAP EPS $0.36 Down From $0.43 YoY, Sales $6.94B Down From $7.17B YoY

Offerings

SILO

Silo Pharma Prices Offering Of 3,333,338 Shares And Series A-1 Warrants At Combined Public Offering Price of $0.60; Gross Proceeds Of ~$2M

Conduit Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) reported quarterly losses of $(1.32) per share. This is a 73.6 percent increase over losses of $(5.00) per share from the same period last year.

Conduit Pharmaceuticals Q1 EPS $(1.32) Up From $(5.00) YoY

Branchout Food (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) reported quarterly losses of $(0.11) per share. This is a 57.69 percent increase over losses of $(0.26) per share from the same period last year. The company reported $3.19 million in sales this quarter. This is a 117.72 percent increase over sales of $1.47 million the same period last year.

Branchout Food Q1 EPS $(0.11) Up From $(0.26) YoY, Sales $3.19M Up From $1.47M YoY

California Governor Gavin Newsom (D) has put forth a proposal to halt new enrollments of undocumented immigrants in a state-funded healthcare program as a strategy to address a $12 billion deficit.
What Happened: Newsom unveiled his nearly $322 billion state spending plan for the upcoming fiscal year on Wednesday. The plan outlines steps to address unexpectedly high Medicaid spending and a volatile economic environment, factoring in federal tariff policies and an unstable stock market, <a href="https://fortune.com/article/gavin-newsom-california-12-billion-deficit-medicaid-spending/">reported</a> Fortune.
The proposed freeze would prevent low-income adults without legal status from applying for Medi-Cal, California&#8217;s Medicaid program, beginning in 2026. However, those already enrolled will remain covered and the changes will not affect children. From 2027, adults with "unsatisfactory immigration status" on Medi-Cal will be required to pay a $100 monthly premium, aligning with the average cost of subsidized health plans in California&#8217;s marketplace.
Newsom criticized President Donald Trump&#8216;s economic policies, suggesting they could decrease&nbsp;state revenues by $16 billion&nbsp;in the future. He stated, &#8220;California is under assault. We&nbsp;have a president that's been&nbsp;reckless in terms of assaulting&nbsp;those growth engines.&#8221;
Newsom&#8217;s office projects that these changes will save the state $5.4 billion by the 2028–2029 fiscal year.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a>
Why It Matters: Newsom&#8217;s decision highlights a notable change in his stance. California expanded free health care to all low-income adults regardless of immigration status, aiming for universal coverage, a plan spearheaded by the Governor himself. However, the program cost $2.7 billion more than expected, with over 1.6 million undocumented individuals enrolled this fiscal year, as per the budget.
In March, Newsom refused to cut health benefits for immigrants despite a $6.2 billion Medicaid shortfall, defending the state-funded program as a long-term cost saver that doesn&#8217;t rely on federal funds.
This proposal comes at a time when&nbsp;California&#8217;s economy has grown to become the world&#8217;s <a href="https://www.benzinga.com/25/04/45002621/california-overtakes-japan-to-become-worlds-fourth-largest-economy-progress-threatened-by-reckless-tariff-policies-warns-governor-newsom">fourth-largest</a>, surpassing Japan. However, according to Newsom, the state has been grappling with economic instability due to federal tariff policies, which he has&nbsp;<a href="https://www.benzinga.com/markets/25/04/44857255/california-becomes-the-first-state-to-sue-trump-over-unlawful-tariff-regime-seeking-to-declare-it-null-and-void-global-trade-policy-is-not-just-a-game">publicly criticized</a>&nbsp;and even&nbsp;<a href="https://www.benzinga.com/news/25/05/45391448/fighting-back-with-facts-ca-gov-newsom-is-done-with-the-trolls-launches-website-to-shut-down-lies-about-worlds-4th-largest-economy">fought against</a>. 
The proposed Medicaid enrollment freeze is part of a broader effort to manage the state&#8217;s finances amid these challenges. However, several Republicans as well as Democrats have criticized Newsom&#8217;s decision. 
Masih Fouladi, executive director of the California Immigrant Policy Center, stated, "The proposal just doesn't match with our values as a state,&#8221; while Sen. Dave Cortese said, "Congress may be walking away from its obligation to the poor, the elderly and the disabled, but California will not."
At the same time, Republican Leader James Gallagher&nbsp;slammed Newsom for blaming Trump and reasoned that the budget deficit was due to Newsom&#8217;s &#8220;reckless spending, false promises and failed leadership."
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45426516/chuck-schumer-says-trump-is-letting-cartel-members-into-the-us-asks-how-much-memecoin-did-" target="_blank" rel="noreferrer noopener">Chuck Schumer Says Trump Is &#8216;Letting Cartel Members&#8217; Into The US, Asks How Much &#8216;Memecoin&#8217; Did They Pay</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Economics

General

Gavin Newsom Proposes Freezing Healthcare Access for Undocumented Immigrants Amid California's $12 Billion Deficit: Governor Blames Trump As Republicans Slam 'False Promises and Failed Leadership'

Kartoon Studios (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOON#NYSE">TOON</a>) reported quarterly losses of $(0.14) per share. This is a 30 percent increase over losses of $(0.20) per share from the same period last year. The company reported $9.50 million in sales this quarter. This is a 56.37 percent increase over sales of $6.08 million the same period last year.

TOON

Kartoon Studios Q1 EPS $(0.14) Up From $(0.20) YoY, Sales $9.50M Up From $6.08M YoY

SINTX Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) reported quarterly losses of $(1.29) per share which missed the analyst consensus estimate of $(0.76) by 69.74 percent. This is a 94.14 percent increase over losses of $(22.00) per share from the same period last year. The company reported quarterly sales of $369.00 thousand which missed the analyst consensus estimate of $725.00 thousand by 49.10 percent. This is a 46.29 percent decrease over sales of $687.00 thousand the same period last year.

Earnings Misses

SINT

SINTX Technologies Q1 EPS $(1.29) Misses $(0.76) Estimate, Sales $369.00K Miss $725.00K Estimate

JX Luxventure Limited - Common Stock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) reported quarterly earnings of $0.86 per share. This is a 54.97 percent decrease over earnings of $1.91 per share from the same period last year. The company reported $49.84 million in sales this quarter. This is a 56.53 percent increase over sales of $31.84 million the same period last year.

JX Luxventure Limited - Common Stock FY24 EPS $0.86 Down From $1.91 YoY, Sales $49.84M Up From $31.84M YoY

<ul>
<li>UNH</li>
<li>WMT</li>
<li>TSLA</li>
<li>NVDA</li>
<li>GLD</li>
<li>BABA</li>
<li>GOOGL</li>
<li>BULL</li>
<li>AAPL</li>
<li>PLTR</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

BABA

BULL

GOOGL

NVDA

PLTR

TSLA

Top 10 Trending Stocks On WallStreetBets As Of May 15, 2025 (Via Swaggy Stocks)

Macquarie analyst Paul Golding maintains IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) with a Outperform and raises the price target from $15.5 to $20.

Price Target

Analyst Ratings

IREN

Macquarie Maintains Outperform on IREN, Raises Price Target to $20

Foxx Development Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXX#NASDAQ">FOXX</a>) reported quarterly losses of $(0.58) per share. This is a 114.81 percent decrease over losses of $(0.27) per share from the same period last year. The company reported $11.39 million in sales this quarter. This is a 2.12K percent increase over sales of $513.84 thousand the same period last year.

FOXX

Foxx Development Hldgs Q3 EPS $(0.58) Down From $(0.27) YoY, Sales $11.39M Up From $513.84K YoY

Atara Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) reported quarterly earnings of $3.50 per share which beat the analyst consensus estimate of $(1.98) by 276.77 percent. This is a 160.87 percent increase over losses of $(5.75) per share from the same period last year. The company reported quarterly sales of $98.15 million which beat the analyst consensus estimate of $5.67 million by 1.63K percent. This is a 258.77 percent increase over sales of $27.36 million the same period last year.

ATRA

Atara Biotherapeutics Q1 EPS $3.50 Beats $(1.98) Estimate, Sales $98.15M Beat $5.67M Estimate

Macro Economic Events

Econ #s

USA Industrial Production (MoM) For April 0.0% Vs 0.2% Est.; -0.3% Prior

Macquarie analyst Paul Golding maintains CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) with a Neutral and raises the price target from $56 to $65.

CRWV

Macquarie Maintains Neutral on CoreWeave, Raises Price Target to $65

Silicon Valley's headline feud just moved from boardrooms to every iPhone screen. As of mid-April, <a href="https://www.cnet.com/tech/mobile/meta-removes-use-of-apple-intelligence-in-its-apps-on-iphone/">CNET</a> reported that Apple Intelligence—Apple's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) new on-device AI suite—no longer works inside Facebook, Instagram, WhatsApp, Threads or Messenger.&nbsp;
The silent change traced back to Meta Platforms&nbsp; (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), which disabled Apple's application interfaces without fanfare.&nbsp;
The clash arrives three months after Meta CEO Mark Zuckerberg said on "<a href="https://www.youtube.com/watch?v=7k1ehaE0bdU&amp;pp=ygUfbWFyayB6dWNrZXJiZXJnIGpvZSByb2dhbiBhcHBsZQ%3D%3D">The Joe Rogan Experience</a>" podcast in January that Apple "hasn't invented anything great since the iPhone." Investors are now gauging what this turf war means for mobile AI.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
<h2 class="wp-block-heading">Silicon Valley's Latest Turf War</h2>
Error messages appeared first, as iPhone owners tried to launch Apple's Writing Tools or Genmoji inside Meta's apps.<a href="https://www.pcmag.com/news/meta-blocks-apple-intelligence-features-on-facebook-instagram-threads"> PCMag</a> reported that the features still load in Safari, signaling a targeted block rather than a system outage.
Meta's own numbers explain the timing. A <a href="https://www.facebook.com/zuck/posts/pfbid0219ude255AKkmk4JAueXZeZ9zpjNYio2tBkd7bNmCaRbJ6iJaVVjypUgDg78CNdq5l">Facebook post</a> by Zuckerberg indicates capital spending could rocket to $65 billion in 2025 from $35 billion last year. Those dollars fund custom silicon and fresh server farms. One upcoming facility will draw two gigawatts of electricity—the output of twin nuclear reactors.&nbsp;
All that infrastructure feeds Meta AI, the assistant now woven through Facebook, Instagram and WhatsApp. Shutting out Apple nudges millions toward Meta's own chatbot for caption rewrites and sticker generation.
Trending: The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a>
Apple introduced Apple Intelligence on June 10, during its Worldwide Developers Conference in Cupertino, California. A company <a href="https://www.apple.com/newsroom/2024/06/introducing-apple-intelligence/">said </a>that the language-and-vision models run on the A17 Pro chip and relay minimal data to the cloud, pitching faster responses and stronger privacy than server-side peers.
Data from<a href="https://www.alphaquery.com/stock/AAPL/volatility-option-statistics/30-day/historical-volatility"> AlphaQuery</a> show 30-day historical volatility for Apple shares hit 0.7775 on April 22. Meanwhile, analysts surveyed by<a href="https://finance.yahoo.com/news/apple-stock-down-23-time-120000645.html"> Yahoo Finance</a> expect revenue to climb only 4.2% in fiscal 2025, a stark slowdown from pandemic-era booms.
Apple CEO Tim Cook met with Commerce Secretary Howard Lutnick on April 17 and secured temporary tariff exemptions covering iPhones and MacBooks as fresh China tariffs loomed, according to media reports.&nbsp;
Zuckerberg's criticism of Apple&#8217;s App Store policies has history, particularly its 30% commission fee, which he has described as &#8220;monopoly rents.&#8221;&nbsp;
According to a 2020 <a href="https://www.buzzfeednews.com/article/pranavdixit/zuckerberg-apple-monopoly">Buzzfeed report</a>, Zuckerberg said that Apple&#8217;s control over the App Store &#8220;blocks innovation, blocks competition,&#8221; and allows the company to &#8220;charge monopoly rents.&#8221; He emphasized that Apple has a &#8220;unique stranglehold as a gatekeeper on what gets on phones.&#8221;
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
Image: Shutterstock

Mark Zuckerberg Says 'Apple Hasn't Invented Anything Great Since The iPhone' As Meta Blocks Its AI Tools

Deutsche Telekom (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DTEGY#OTC">DTEGY</a>) reported quarterly earnings of $0.53 per share. This is a 8.16 percent increase over earnings of $0.49 per share from the same period last year. The company reported $31.29 billion in sales this quarter. This is a 3.11 percent increase over sales of $30.35 billion the same period last year.

DTEGY

Deutsche Telekom Q1 Adj. EPS $0.53 Up From $0.49 YoY, Sales $31.29B Up From $30.35B YoY

US Capacity Utilization Rate (Apr)	77.7% vs 77.8% Est.

Press Releases

Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Financing

Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms

Health Care

Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™

Legal

Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

Management

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

CSE:HUGE

CSE:QNTM

HUGE

Comments

Quantum BioPharma

Noticias

Últimas noticias sobre Quantum BioPharma (NASDAQ:QNTM) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL